Senior Director, Quality
Regeneron Pharmaceuticals
Summary
Regeneron is hiring a Sr. Director/Executive Director of Quality for a new highly automated bulk/drug substance manufacturing plant, supporting 20–30 tech transfers a year alongside commercial delivery responsibility. GMP production will run concurrently with construction and CQV for 3–5 years. This role requires both building and operating.
Job description
Discover your role
- Own the site quality system (both QA & QC) and lead a culture of compliance, accountability, and right-first-time execution
- QA: ops, systems, and validation owned directly alongside QC as part of a unified site quality organization
- QC: responsible for delivering utilities, in-process and release testing, performing environmental monitoring, QC laboratory compliance, and method transfer support that enable timely, compliant batch release
- Oversee these functions OpEx and CapEx budget and roadmap
- Serve as the primary party responsible for this function's alignment with the Global Center of Excellence (COE)
- Ensure this function's metrics flow up and down through the MDI structure, connecting into the site's S&OP, AOP, and long-range planning cycles
- Hold batch disposition authority, ensuring compliance and timely batch release
- Own and manage all regulatory inspections ensuring the site is continuously inspection-ready and leading the site through regulatory agency inspections and customer and corporate audits
- Serve as the site's primary conduit for quality metrics, quality system work, and quality strategy connecting site execution to enterprise quality's vision for best-in-class lean quality operations
- Provide governance of laboratory investigations, deviations, and CAPA management across all quality sub-functions
- Lead all aspects of batch record review and disposition support, floor quality presence, and deviation management for manufacturing for Saratoga Site
- Lead all aspects of QMS administration, document control, training compliance, CAPA system administration, and audit readiness for Saratoga Site
- Build and coordinate best-in-class validation programs process, cleaning, and equipment validation grounded in FDA's three-stage process validation lifecycle, EU Annex 15, ASTM E2500 risk-based qualification, and ICH Q8–Q11 Quality by Design principles tailored to large-molecule biotech manufacturing, including PPQ support for new suite introduction
- Lead quality readiness for suites entering service, including validation, qualification, and quality system scale-up
- Partner with manufacturing, technical services, technical operations, and supply chain as a core member of the site leadership team
- Own quality's role in the digital and connected plant model, including electronic quality systems, review by exception, and data integrity by design
- Build, coach, and retain a high-performing quality organization; establish high standards for performance management and accountability
- Lead a gross margin improvement program and goal for this function, contributing to the site's overall margin performance
- Own and manage the site's data governance program, including data integrity standards, data ownership and accountability, lifecycle controls, and periodic review
- Own and manage the site's quality management maturity, including assessing current state against enterprise and industry benchmarks, setting the improvement roadmap, and driving measurable gains in quality system performance
- Own and manage the site's contamination control strategy, including its design, governance, and day-to-day execution across facility, equipment, process, personnel, and materials, with ongoing trending and review of effectiveness
This role requires
- B.S in Life Sciences, Engineering, or a related technical field
- Sr. Director: 15+ years in biopharmaceutical quality, large-molecule drug substance operations and/or medical device quality including 7+ years of progressive quality leadership
- Executive Director: 18+ years in biopharmaceutical quality, large-molecule drug substance operations and/or medical device quality experience including 7+ years of progressive quality leadership
- Level will be determined based on experience
- Experience with batch disposition and release decision-making in a GMP environment
- Previous people leadership/supervisory experience
Requirements
- B.S in Life Sciences, Engineering, or a related technical field
- 15+ years in biopharmaceutical quality, large-molecule drug substance operations and/or medical device quality (Sr. Director)
- 18+ years in biopharmaceutical quality, large-molecule drug substance operations and/or medical device quality (Executive Director)
- 7+ years of progressive quality leadership
- Experience with batch disposition and release decision-making in a GMP environment
- Previous people leadership/supervisory experience
Benefits
- Annual bonuses
- Incentive plans
- Equity awards
- Pension or retirement benefits
- 401(k) company match
- Health and wellness programs
- Fitness centers
- Medical, Dental & Vision
- Life and disability insurance
- Paid time off
- Family support benefits
Company overview
Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.